FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Raban Jeger

Research Profile

Disorders

Procedures

Concepts & Ideas

Devices

Chemicals & Drugs

Platelet Aggregation Inhibitors

Geographic Areas

Switzerland

Co-author Network

Publications

TOP 3
S Muenst; S D Soysal; Niels Willi; Gieri Cathomas; Raban V Jeger; Katharina Glatz
[Embolization of hydrophilic guide wire coating].
T Burkard; Raban V Jeger; Christoph A Kaiser; Stefan Osswald; Matthias E Pfisterer; Hans Peter Brunner-La Rocca
Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
Michael J Zellweger; Franziska Bader; Hans Peter Brunner-La Rocca; Peter Buser; Raban V Jeger; Christoph Kaiser; Jan Mueller-Brand; Matthias Pfisterer
Coronary artery disease progression late after successful stent implantation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Raban Jeger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: S Muenst; S D Soysal; Niels Willi; Gieri Cathomas; Raban V Jeger; Katharina Glatz
[Embolization of hydrophilic guide wire coating].
Der Pathologe 2012;33(4):345-7.
2012: T Burkard; Raban V Jeger; Christoph A Kaiser; Stefan Osswald; Matthias E Pfisterer; Hans Peter Brunner-La Rocca
Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
Journal of internal medicine 2012;271(3):257-63.
2012: Michael J Zellweger; Franziska Bader; Hans Peter Brunner-La Rocca; Peter Buser; Raban V Jeger; Christoph Kaiser; Jan Mueller-Brand; Matthias Pfisterer
Coronary artery disease progression late after successful stent implantation.
Journal of the American College of Cardiology 2012;59(9):793-9.
2012: Raban V Jeger
New therapies for cardiogenic shock.
Minerva cardioangiologica 2012;60(1):101-9.
2012: Raban V Jeger; Jan Skov Jensen; Hannes Alber; Franz R Eberli; Søren Galatius; Nicole Gilgen; Christoph Naber; Giovanni B Pedrazzini; Matthias Pfisterer; Hans Rickli; André Vuilliomenet; Christoph Kaiser
Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design.
American heart journal 2012;163(2):136-41.e1.
2011: Raban V Jeger; M E Pfisterer
Primary PCI in STEMI--dilemmas and controversies: multivessel disease in STEMI patients. Complete versus Culprit Vessel revascularization in acute ST--elevation myocardial infarction.
Minerva cardioangiologica 2011;59(3):225-33.
2011: Raban V Jeger; Philip Urban; Shannon M Harkness; Chi-Hong Tseng; Jean-Christophe Stauffer; Thierry H LeJemtel; Lynn A Sleeper; Matthias E Pfisterer; Judith S Hochman
Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials.
Acute cardiac care 2011;13(1):14-20.
2010: Raban V Jeger
Drug-eluting stents for saphenous vein graft lesions: useful or harmful?
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2010;5(6):647-8.
2009: Raban V Jeger; Hans Peter Brunner-La Rocca; Patrick R Hunziker; Dimitrios A Tsakiris; Christoph A Kaiser; Matthias E Pfisterer
Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.
Clinical therapeutics 2009;31(12):2886-93.
2009: Christophe Hälg; Hans Peter Brunner-La Rocca; Christoph Kaiser; Raban V Jeger; Stefan Osswald; Matthias Pfisterer; Andreas Hoffmann
Early and late increased bleeding rates after angioplasty and stenting due to combined antiplatelet and anticoagulanttherapy.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2009;5(4):425-31.
2009: Raban V Jeger; Hans Peter Brunner-La Rocca
Ischaemic mitral regurgitation.
European heart journal 2009;30(13):1573.
2009: Raban V Jeger; Stefan Schneiter; Christoph Kaiser; Piero O Bonetti; Hans Peter Brunner-La Rocca; Michael Handke; Stefan Osswald; Peter T Buser; Matthias E Pfisterer
Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions.
Cardiology 2009;112(1):49-55.
2008: Raban V Jeger; Dragana Radovanovic; Patrick R Hunziker; Matthias E Pfisterer; Jean-Christophe Stauffer; Paul Erne; Philip Urban
Ten-year trends in the incidence and treatment of cardiogenic shock.
Annals of internal medicine 2008;149(9):618-26.
2008: Raban V Jeger; Peter Rickenbacher; Matthias E Pfisterer; Andreas Hoffmann
Outpatient rehabilitation in patients with coronary artery and peripheral arterial occlusive disease.
Archives of physical medicine and rehabilitation 2008;89(4):618-21.
2007: Raban V Jeger; April M Lowe; Christopher E Buller; Matthias E Pfisterer; Vladimir Dzavik; John G Webb; Judith S Hochman; Ulrich P Jorde
Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK Trial.
Chest 2007;132(6):1794-803.
2007: Hans Peter Brunner-La Rocca; Christoph Kaiser; Alain Bernheim; Michael J Zellweger; Raban V Jeger; Peter T Buser; Stefan Osswald; Matthias Pfisterer
Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis.
Lancet 2007;370(9598):1552-9.
2007: Michael E Farkouh; Jeffrey D Greenberg; Raban V Jeger; Krishnan Ramanathan; Freek W A Verheugt; James H Chesebro; H Kirshner; Judith S Hochman; C L Lay; Sean Ruland; Bernhard Mellein; Patrice Matchaba; V Fuster; Steven B Abramson
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.
Annals of the rheumatic diseases 2007;66(6):764-70.
2007: Raban V Jeger; Lucas Jörg; Peter Rickenbacher; Matthias E Pfisterer; Andreas Hoffmann
Benefit of outpatient cardiac rehabilitation in under-represented patient subgroups.
Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine 2007;39(3):246-51.
2007: Raban V Jeger; Susan F Assmann; Loran Yehudai; Krishnan Ramanathan; Michael E Farkouh; Judith S Hochman
Causes of death and re-hospitalization in cardiogenic shock.
Acute cardiac care 2007;9(1):25-33.
2007: Raban V Jeger; Manfred D Seeberger; Ulrich Keller; Matthias E Pfisterer; Miodrag Filipovic
Oral hypoglycemics: increased postoperative mortality in coronary risk patients.
Cardiology 2007;107(4):296-301.
2006: Matthias Pfisterer; Hans Peter Brunner-La Rocca; Peter T Buser; Peter Rickenbacher; Patrick Hunziker; Christian Mueller; Raban V Jeger; Franziska Bader; Stefan Osswald; Christoph Kaiser
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
Journal of the American College of Cardiology 2006;48(12):2584-91.
2006: Raban V Jeger; Chi-Hong Tseng; Judith S Hochman; Eric R Bates
Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock--a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry.
American heart journal 2006;152(4):686-92.
2006: Rana Billeh; David S Hirsh; Colin Barker; Birgit Jorgensen; Raban V Jeger; Krishnan Ramanathan; Chi-Hong Tseng; Alhakam Hudaihed; Francois Haas; Ulrich P Jorde
Randomized, double-blind comparison of acute beta1-blockade with 50 mg metoprolol tartrate vs 25 mg carvedilol in normal subjects.
Congestive heart failure (Greenwich, Conn.) 2006;12(5):254-7.
2006: Christoph Kaiser; Raban V Jeger; S Wyrsch; L Schoeb; Gabriela M Kuster; Peter T Buser; Stefan Osswald; Franziska Bernet; Wolfgang Brett; Leticia Grize; Matthias Pfisterer
Selection bias of elderly patients with chronic angina referred for catheterization.
International journal of cardiology 2006;110(1):80-5.
2006: Raban V Jeger; Shannon M Harkness; Krishnan Ramanathan; Christopher E Buller; Matthias E Pfisterer; Lynn A Sleeper; Judith S Hochman
Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry.
European heart journal 2006;27(6):664-70.
2006: Raban V Jeger; Cecilia Probst; Ruza Arsenic; Thomas Lippuner; Matthias E Pfisterer; Manfred D Seeberger; Miodrag Filipovic
Long-term prognostic value of the preoperative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease.
American heart journal 2006;151(2):508-13.
2005: Raban V Jeger; Piero O Bonetti; Michael J Zellweger; Daniel Tobler; Christoph A Kaiser; Stefan Osswald; Peter T Buser; Matthias E Pfisterer
Influence of revascularization on long-term outcome in patients > or =75 years of age with diabetes mellitus and angina pectoris.
The American journal of cardiology 2005;96(2):193-8.
2005: Raban V Jeger; Jeffrey D Greenberg; Krishnan Ramanathan; Michael E Farkouh
Lumiracoxib, a highly selective COX-2 inhibitor.
Expert review of clinical immunology 2005;1(1):37-45.
2005: Miodrag Filipovic; Raban V Jeger; Thierry Girard; Cecilia Probst; Matthias Pfisterer; Lorenz Gürke; Wolfgang Studer; Manfred D Seeberger
Predictors of long-term mortality and cardiac events in patients with known or suspected coronary artery disease who survive major non-cardiac surgery.
Anaesthesia 2005;60(1):5-11.
2004: Raban V Jeger; Michael J Zellweger; Christoph Kaiser; Leticia Grize; Stefan Osswald; Peter T Buser; Matthias E Pfisterer
Prognostic value of stress testing in patients over 75 years of age with chronic angina.
Chest 2004;125(3):1124-31.
2003: Miodrag Filipovic; Raban V Jeger; Cecilia Probst; Thierry Girard; Matthias Pfisterer; Lorenz Gürke; Karl Skarvan; Manfred D Seeberger
Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease.
Journal of the American College of Cardiology 2003;42(10):1767-76.
2003: Michael J Zellweger; Markus Weinbacher; Andreas W Zutter; Raban V Jeger; Jan Mueller-Brand; Christoph Kaiser; Peter T Buser; Matthias E Pfisterer
Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting.
Journal of the American College of Cardiology 2003;42(1):33-40.